Study Uncovers Genetic Factors Behind Leishmaniasis Outcomes
November 25th 2019A new study published in Science Translational Medicine reveals that genetic testing can identify patients with leishmaniasis unlikely to respond to conventional treatments, allowing clinicians to find candidates for alternative therapies ahead of time.
TAF vs. TDF: Measuring Lipid Levels in HIV Treatment
November 22nd 2019TAF causes cholesterol levels to rise, but that includes levels of “good cholesterol” HDL. Researchers concluded that there is no significant difference in cardiovascular risk profiles between people taking TAF and those taking TDF.